Security · featured owners
Engene Therapeutics Inc.
Engene Therapeutics Inc. COM Equity as of 2026 Q2 among managers we track
- 1 Owner
- Max 0.0%
- $129K
- 1 new
Engene Therapeutics Inc. is held in 1 featured 13F book as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (0.02%). Figures are as-filed 13F, not free float.
Who owns this now
Largest portfolio weights among featured holders · max 0.0% (Nathan Fischel - Dafna Capital Management) · not free-float ownership
holders
sorted by value · long equity only · current book 2026 Q2 · open a manager for their book
| history | |||||
|---|---|---|---|---|---|
| Nathan Fischel - Dafna Capital Management 2026 Q2 | 0.02% | New 0.02% | 74,650 | $129K | history |
ownership over time
filing count by report period · click a bar for that quarter’s holders